1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Reproductive Sterility in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Favaedi, R; Mahdian, S; Moini, A; Movahedi, M; Pirjani, R; Shahhoseini, M | 1 |
| Baka, S; Creatsas, G; Grigoriou, O; Hassiakos, D; Konidaris, S; Makrakis, E; Papadias, K | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Reproductive Sterility
| Article | Year |
|---|---|
Effect of sperm treatment with exogenous platelet-activating factor on the outcome of intrauterine insemination.
Topics: Adult; Female; Humans; Infertility; Insemination, Artificial, Homologous; Male; Platelet Activating Factor; Pregnancy; Pregnancy Rate; Prospective Studies; Spermatozoa; Treatment Outcome | 2005 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Reproductive Sterility
| Article | Year |
|---|---|
Platelet-activating factor and antiphospholipid antibodies in recurrent implantation failure.
Topics: Adult; Antibodies, Antiphospholipid; Case-Control Studies; Embryo Implantation; Female; Fertilization in Vitro; Humans; Infertility; Platelet Activating Factor; Pregnancy; Treatment Failure | 2021 |